Env Health Session: Public AM, Private PM Trade Secret Huddle
Published Date: 8/3/2026
Notice
Summary
The National Institute of Environmental Health Sciences is holding a partly open meeting on September 10, 2026, to discuss program policies and review grant applications. The morning session is open to the public online, while the afternoon session is closed to protect private info and trade secrets. Researchers and grant applicants should note this important date for updates and decisions that could impact funding.
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-18937, Proposed Collection; 60-Day Comment Request; NIH Intramural Reporting of Research Misconduct (IRRM) Web Form (Office of the Director/Office of Intramural Research)
The NIH Intramural Research Program (IRP) relies on a trustworthy research record to sustain public confidence and advance public health. NIH maintains procedures in compliance with NIH policy and 42 CFR part 93 to evaluate allegations of research misconduct, including falsification, fabrication, and plagiarism, through a fair, consistent, and peer-informed process. The proposed web-based reporting form will help the Agency Intramural Research Integrity Officer (AIRIO) receive sufficient information needed to assess concerns and determine appropriate next steps. Reports may be submitted anonymously, with optional contact information for follow-up. Concerns may also be reported in person, by telephone, or by email.
2026-18877, Prospective Grant of an Exclusive Patent License: Development and Commercialization of Engineered Cell Therapies for the Treatment of HPV 16 E6-Expressing Cancers
The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the patents and patent applications listed in the Supplementary Information section of this notice to MedGene Therapeutics, Inc. ("MedGene"), a company located in Silver Spring, Maryland, the United States of America.
2026-18646, Draft NIH Biosafety Policy for Research Involving Biohazards
The NIH is updating its biosafety rules to keep research safe as science changes and grows. This new policy will replace old guidelines and affect anyone working with biohazards in NIH-funded research. They want your thoughts by October 19, 2026, to help shape these important safety updates without adding extra costs.
2026-18191, Submission for OMB Review; 30-Day Comment Request Data and Specimen Hub (DASH) (Eunice Kennedy Shriver National Institute of Child Health and Human Development)
The National Institutes of Health (NIH) is asking for public feedback on their Data and Specimen Hub (DASH), which helps researchers share important health data. This is a quick 30-day review to make sure the information collection is clear and useful. If you’re involved in health research or data sharing, your input by October 8, 2026, can help shape how DASH works without costing extra money or time.
2026-17899, Proposed Collection; 60-Day Comment Request; Assurance (Interinstitutional, Foreign, and Domestic) and Annual Report (Office of the Director)
The NIH wants your thoughts on their plan to keep track of animal research safety through yearly reports and assurances from institutions, both in the U.S. and abroad. This helps make sure labs follow the rules and protect animals, with no new costs or big changes expected. You’ve got until October 2, 2026, to share your feedback and help improve the process!
2026-17687, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in October 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, ensuring fair and confidential decisions. Scientists applying for grants in genetics, molecular sciences, oral health, and cancer research are the ones affected, with no direct cost changes announced.
Previous / Next Documents
Previous: 2026-15621, Self-Regulatory Organizations; ICE Clear Credit LLC; Order Approving Proposed Rule Change Relating to the Clearance of Additional Credit Default Swap Contracts
Next: 2026-15626, National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Partially Closed Meeting
The National Institute of Arthritis and Musculoskeletal and Skin Diseases is holding a meeting on September 15, 2026, that’s partly open to the public and partly closed. People interested in arthritis and skin disease research can join the open sessions online or in person, while grant reviews will happen privately. This meeting helps decide which research projects get funding, impacting future health studies and budgets.